Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 15, 2006
Moderate to severe thrombocytopenia during pregnancyMichal Parnas, Eyal Sheiner, Ilana Shoham-Vardi, et al.
International Journal of Hematology|July 2, 2021
Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantationIvetta Danylesko, Rina Sareli, Nira Varda-Bloom, et al.
Bone Marrow Transplantation|April 24, 2024
Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantationYana Davidov, Noga Shem-Tov, Ronit Yerushalmi, et al.
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|November 12, 2025
Characteristics of Acyclovir-Resistant Herpes Simplex Virus Infection in Hematological PatientsReema Shehadeh, Mor Bar Ilan, Sara Dovrat, et al.
European Journal of Haematology|July 24, 2019
Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantationRoni Shouval, Elizaveta Kouniavski, Joshua Fein, et al.
Cancer|November 13, 2014
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemiaAvichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, et al.
Blood Advances|June 22, 2019
External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantationRoni Shouval, Joshua A Fein, Aniela Shouval, et al.
Annals of Hematology|October 14, 2014
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantationMaya Koren-Michowitz, Hannah Maayan, Arie Apel, et al.
British Journal of Haematology|August 1, 2025
Bisantrene in combination with fludarabine and clofarabine as salvage therapy for adult patients with refractory or relapsed acute myeloid leukaemia (AML)-An open-label, phase I/II studyIvetta Danylesko, Avichai Shimoni, Abraham Avigdor, et al.
Cancer|June 22, 2010
Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-upAvichai Shimoni, Izhar Hardan, Francis Ayuk, et al.
Pageof 7